Scientists were able to create a bespoke treatment for KJ Muldoon’s rare genetic disorder within six months. It could be a blueprint for potentially life-saving, gene-editing Crispr therapies.
Vicarious and SS marked progress toward bringing their robotic surgery systems to the U.S. market. The companies are among a new generation of robot developers looking to challenge Intuitive Surgical.
The IPO market has been largely dormant across the tech sector for the past three years, and within digital health, it’s been almost completely dead. After President Donald Trump announced a sweeping tariff policy that plunged U.S. markets into turmoil last month, taking a company public is an even riskier endeavor. Online lender Klarna delayed its long-anticipated IPO, as did ticket marketplace StubHub.
President Donald Trump's push to cut billions of dollars in government contracts is rattling the niche community of scientists who collect, study and share human brains. Two of the country's brain banks, which have worked with the government to store and distribute specimens to researchers studying diseases like Parkinson's and ALS for more than a decade, told POLITICO they had temporarily stopped taking new donations for fear the administration would not renew their contracts.